Our commitment to the rare disease community requires Pharming to be a sustainable partner for all stakeholder groups including but not limited to patients, employees, healthcare professionals, third-party suppliers and partners, our shareholders, and the wider society.
Pharming is headquartered in Leiden, the Netherlands with its U.S. headquarters located in Warren, New Jersey. Pharming is dually listed on the Euronext Amsterdam (PHARM) and Nasdaq (PHAR) exchanges.
Our strategy
Our vision is to become a leading global rare disease company with a diverse portfolio and presence in large markets, by leveraging proven and efficient clinical development, supply chain and commercial infrastructure.
We are leveraging our existing portfolio with a goal of delivering continued short-term growth. In APDS, we expect to continue to identify and enroll new patients, supported by VUS resolution efforts, and prepare for launches in key countries outside the U.S.
and expansion of the product label to the pediatric population.
We are investing in our long-term growth, with potential new indications in PIDs with immune dysregulation
which could significantly expand the addressable patient population. Our pivotal stage clinical program in primary mitochondrial diseases brings another pipeline opportunity
with what we believe is large revenue potential. We will also continue to assess value-accretive opportunities to broaden
our pipeline.
We believe these growth opportunities, combined with a focus
on organization efficiency, provide the foundation to realize our vision, deliver sustainable value, and fulfill our mission to serve the unserved rare disease patients.
Our Company Culture
As a leading biopharmaceutical company, we focus on serving the unserved rare disease patient and bringing them the solutions they need.
Together, we can achieve great things. By collaborating, encouraging each other to go the extra mile and listen, assist and support even when things get tough. Combining each others' expertise leads to our continued growth, not only in size but also in the impact we have on patients.
We are working together to create our future. It inspires us to go above and beyond for our patients. It is important that employees feel connected and engaged. Our Core Values and Behaviors are therefore an essential part of our company strategy.
